טוען...

Co-administration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs

Poor penetration of anti-cancer drugs into tumors can be an important factor limiting their efficacy. Studying mouse tumor models, we show that a previously characterized tumor-penetrating peptide, iRGD (CRGDK/RGPD/EC), increased vascular and tissue permeability in a tumor-specific and neuropilin-1-...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Sugahara, Kazuki N., Teesalu, Tambet, Karmali, Priya Prakash, Kotamraju, Venkata Ramana, Agemy, Lilach, Greenwald, Daniel R., Ruoslahti, Erkki
פורמט: Artigo
שפה:Inglês
יצא לאור: 2010
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2881692/
https://ncbi.nlm.nih.gov/pubmed/20378772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.1183057
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!